Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Flagship Global Health And China Healthcare Ink Deal To Expand Insurance Services In China

This article was originally published in PharmAsia News

You may also be interested in...



China’s MOH-SFDA Merger: Analysts Weigh In

SHANGHAI - China has reorganized the Ministry of Health and put the State FDA under its jurisdiction. The State Council's institutional restructuring scheme was officially approved March 15 at the first session of the 11 National People's Congress held in Beijing

Medical Insurance Plan Expected To Boost Size Of China Pharma Market

SHANGHAI - China's basic medical insurance program will cover all urban residents in the country by the end of this year, the State Council of China announced recently

Sidley Austin Beijing Senior Counsel Chen Yang: An Interview with PharmAsia News

Chen Yang, senior counsel in Sidley Austin's Beijing office, recently spoke with PharmAsia News about recent developments in China that affect the pharmaceutical and medical device industries. Yang leads the firm's China life sciences practice. For the past 10 years, she has advised international companies on their investment projects and acquisition efforts in various Chinese industries and provided regulatory advice on intellectual property, life science, employment and other issues. She has also assisted China government agencies in several U.S. litigation matters.

Latest News
UsernamePublicRestriction

Register

SC068229

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel